Research Area: Drug discovery and repurposing of drugs

JSON
CSV
XLSX
TXT

Primary: Shown in the list of current labels.

Year 2022

PubMed DOI Crossref
Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium.
Mehregan A, Pérez-Conesa S, Zhuang Y, ..., Ulens C, Delemotte L
Biochim Biophys Acta Biomembr 1864 (10) 183994 [2022-10-01; online 2022-06-18]
Category: Biochemistry Category: Health Category: Imaging Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Drug discovery and repurposing of drugs Type: Journal article
PubMed DOI Crossref
COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients.
Sundberg E, Hoffman T, Nilsson A, ..., Harila-Saari A, Palle J
Pediatr Blood Cancer - (-) e29773 [2022-05-25; online 2022-05-25]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Research Area: Pandemic preparedness Type: Journal article
PubMed DOI Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U, Havervall S, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines 10 (3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses.
Luttens A, Gullberg H, Abdurakhmanov E, ..., Danielson UH, Carlsson J
J Am Chem Soc - (-) - [2022-02-10; online 2022-02-10]
Category: Biochemistry Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Research Area: Pandemic preparedness Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C
PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo.
Hanke L, Das H, Sheward DJ, ..., Murrell B, McInerney GM
Nat Commun 13 (1) 155 [2022-01-10; online 2022-01-10]
Category: Biochemistry Category: Health Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Drug discovery and repurposing of drugs Type: Journal article
PubMed DOI Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C
J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

Year 2021

DOI Crossref
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
Almazán NM, Rahbar A, Carlsson M, ..., Sörensen B, Söderberg-Nauclér C
medRxiv - (-) - [2021-12-25; online 2021-12-25]
Category: Genomics & transcriptomics Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Preprint
PubMed DOI Crossref
Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
Bauer W, Weber M, Diehl-Wiesenecker E, ..., Micke P, Kappert K
Viruses 13 (12) 2456 [2021-12-07; online 2021-12-07]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Type: Journal article
DOI Crossref
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Havervall S, Marking U, Gordon M, ..., Hober S, Thålin C
MedRxiv - (-) - [2021-08-12; online 2021-08-12]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Preprint
PubMed DOI Crossref
A phenomics approach for antiviral drug discovery.
Rietdijk J, Tampere M, Pettke A, ..., Puumalainen MR, Carreras-Puigvert J
BMC Biol 19 (1) 156 [2021-08-02; online 2021-08-02]
Category: Biochemistry Category: Drug Discovery Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Drug discovery and repurposing of drugs Type: Journal article
PubMed DOI Crossref
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
Havervall S, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C
EBioMedicine 70 (-) 103523 [2021-08-00; online 2021-08-12]
Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

Year 2020

PubMed DOI Crossref
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E, Leach S, Axelsson H, ..., Liljeqvist JÅ, Gisslén M
PLoS One 15 (10) e0241104 [2020-10-21; online 2020-10-21]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Biomarkers and systems immunology Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
Akaberi D, Krambrich J, Ling J, ..., Lennerstrand J, Lundkvist Å
Redox Biology 37 (-) 101734 [2020-09-21; online 2020-09-21]
Category: Imaging Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Drug discovery and repurposing of drugs Type: Journal article
PubMed DOI Crossref
Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.
Ling J, Hickman RA, Li J, ..., Lundkvist Å, Järhult JD
Viruses 12 (9) - [2020-09-14; online 2020-09-14]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Drug discovery and repurposing of drugs Type: Journal article
PubMed DOI Crossref
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
Nasi A, McArdle S, Gaudernack G, ..., Sjölin J, Mangsbo S
Toxicology Reports 7 (-) 768-771 [2020-00-00; online 2020-00-00]
Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Type: Review
SciLifeLab Data Centre
Publications 9.5.1